There is a connection between alcohol and anxiety the day after you drink for many reasons, even if you’ve not been diagnosed ...

Alcohol use disorder (AUD) is a major global public health issue, affecting more than 28 million adults in the United States ...

While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.

There is initial evidence that low-dose semaglutide may reduce craving and drinking outcomes in individuals with alcohol-use disorder.

For years, people taking GLP-1 type drugs (e.g., Ozempic, Wegovy) have noticed that the medicines didn’t just help them to ...

Teens who have parental permission to drink are more likely to develop unhealthy relationships with alcohol as adults, a ...

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat alcohol use disorder and alcohol-associated liver disease.

The company unveiled plans last week to test its GLP-1/glucagon dual receptor agonist in alcohol use disorder and ...

As health complications and deaths from alcohol use disorder (AUD) increase in the United States, it is critical that people ...

Clearmind Medicine Inc. initiates a Phase I/IIa trial for CMND-100, targeting Alcohol Use Disorder in multiple research institutions. Clearmind Medicine Inc. has launched its Phase I/IIa clinical ...

The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...